Rhythm PharmaceuticalsRYTM
那斯達克 · USD
88.30
+3.07
(+3.60%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Rhythm PharmaceuticalsRYTM
88.30
+3.07
(+3.60%)
財務數據
損益表
- 0.09
- 0.11
- 0.19
- 0.23
- 0.24
- 0.26
- 0.29
- 0.33
- 0.42
- 0.33
- 105.18
- 30.48
- 67.60
- 17.07
- 7.69
- 7.15
- 11.98
- 14.35
- 25.80
- -21.82
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 32,704 | 41,830 | 33,251 | 29,078 | 25,967 | 24,234 | 22,503 | 19,222 | 11,469 | 8,790 |
營業成本 | 3,648 | 3,787 | 3,828 | 2,946 | 2,807 | 3,233 | 2,412 | 2,236 | 1,421 | 1,028 |
營業毛利 | 29,056 | 38,043 | 29,423 | 26,132 | 23,160 | 21,001 | 20,091 | 16,986 | 10,048 | 7,762 |
營業費用 | 76,060 | 79,298 | 73,308 | 66,608 | 163,047 | 62,266 | 64,056 | 63,582 | 62,579 | 49,865 |
研發費用 | 36,973 | 41,168 | 37,931 | 30,193 | 128,665 | 29,892 | 33,572 | 33,542 | 37,945 | 23,548 |
推銷及管理費用 | 39,087 | 38,130 | 35,377 | 36,415 | 34,382 | 32,374 | 30,484 | 30,040 | 24,634 | 26,317 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -47,004 | -41,255 | -43,885 | -40,476 | -139,887 | -41,265 | -43,965 | -46,596 | -52,531 | -42,103 |
其他收入及費用 | 2,995 | 3,320 | 5,663 | 13,297 | 3,570 | 4,378 | 3,063 | 3,281 | 3,413 | 2,621 |
利息費用 | 5,409 | 5,447 | 5,798 | 4,603 | 4,755 | 4,550 | 2,893 | 3,388 | 3,061 | 3,011 |
稅前純益 | -49,418 | -43,382 | -44,020 | -31,782 | -141,072 | -41,437 | -43,795 | -46,703 | -52,179 | -42,493 |
所得稅 | 80 | -90 | -343 | 479 | 300 | 196 | 368 | - | - | - |
稅後純益 | -49,498 | -43,292 | -43,677 | -32,261 | -141,372 | -41,633 | -44,163 | -46,703 | -52,179 | -42,493 |
基本每股稅後盈餘(元) | -0.81 | -0.72 | -0.73 | -0.55 | -2.35 | -0.70 | -0.76 | -0.82 | -0.92 | -0.75 |
稀釋每股稅後盈餘(元) | -0.81 | -0.72 | -0.73 | -0.54 | -2.35 | -0.70 | -0.76 | -0.82 | -0.92 | -0.74 |
基本平均股數(千股) | 63059.00 | 61596.00 | 61219.00 | 61011.00 | 60143.00 | 59211.00 | 57874.00 | 56867.00 | 56708.00 | 56299.00 |
稀釋平均股數(千股) | 63059.00 | 61596.00 | 61219.00 | 61011.00 | 60143.00 | 59211.00 | 57874.00 | 56867.00 | 56708.00 | 56299.00 |
還原基本每股稅後盈餘(元) | -0.81 | -0.72 | -0.73 | -0.55 | -2.35 | -0.70 | -0.76 | -0.82 | -0.92 | -0.75 |
還原稀釋每股稅後盈餘(元) | -0.81 | -0.72 | -0.73 | -0.54 | -2.35 | -0.70 | -0.76 | -0.82 | -0.92 | -0.74 |
還原基本平均股數(千股) | 63,059 | 61,596 | 61,219 | 61,011 | 60,143 | 59,211 | 57,874 | 56,867 | 56,708 | 56,299 |
還原稀釋平均股數(千股) | 63,059 | 61,596 | 61,219 | 61,011 | 60,143 | 59,211 | 57,874 | 56,867 | 56,708 | 56,299 |
EBITDA(千元) | -43,626 | -37,552 | -37,837 | -26,789 | -135,912 | -36,470 | -40,460 | -42,873 | -48,661 | -39,040 |